CA2581966A1 - Group a streptococcus crge protein - Google Patents

Group a streptococcus crge protein Download PDF

Info

Publication number
CA2581966A1
CA2581966A1 CA002581966A CA2581966A CA2581966A1 CA 2581966 A1 CA2581966 A1 CA 2581966A1 CA 002581966 A CA002581966 A CA 002581966A CA 2581966 A CA2581966 A CA 2581966A CA 2581966 A1 CA2581966 A1 CA 2581966A1
Authority
CA
Canada
Prior art keywords
crge
polypeptide
bacterium
crgr
test compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002581966A
Other languages
English (en)
French (fr)
Inventor
Andrea Manetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2581966A1 publication Critical patent/CA2581966A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002581966A 2004-09-27 2005-09-27 Group a streptococcus crge protein Abandoned CA2581966A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0421465.6A GB0421465D0 (en) 2004-09-27 2004-09-27 Group A streptococcus protein
GB0421465.6 2004-09-27
PCT/IB2005/003087 WO2006035311A2 (en) 2004-09-27 2005-09-27 GROUP A STREPTOCOCCUS CrgE PROTEIN

Publications (1)

Publication Number Publication Date
CA2581966A1 true CA2581966A1 (en) 2006-04-06

Family

ID=33397333

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002581966A Abandoned CA2581966A1 (en) 2004-09-27 2005-09-27 Group a streptococcus crge protein

Country Status (6)

Country Link
US (1) US20080131465A1 (enExample)
EP (1) EP1794186A2 (enExample)
JP (1) JP2008514196A (enExample)
CA (1) CA2581966A1 (enExample)
GB (1) GB0421465D0 (enExample)
WO (1) WO2006035311A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
US7709009B2 (en) 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US8287885B2 (en) 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
CN114340648A (zh) * 2019-08-19 2022-04-12 贝勒大学 引导性抗微生物肽的益生菌递送

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69226871T3 (de) * 1991-06-27 2009-09-24 Bristol-Myers Squibb Co. CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
US20020072495A1 (en) * 2000-09-21 2002-06-13 Oleg Chertov LL-37 is an immunostimulant
US7939087B2 (en) * 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
US8933029B2 (en) * 2001-08-24 2015-01-13 Carrus Capital Corporation Antimicrobial and anti-inflammatory peptides
JP2003321392A (ja) * 2002-04-30 2003-11-11 Univ Nihon 粘膜免疫ワクチン用アジュバント
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
JP4366497B2 (ja) * 2002-08-30 2009-11-18 独立行政法人農業・食品産業技術総合研究機構 生体膜に特異的に作用する新規なペプチド

Also Published As

Publication number Publication date
US20080131465A1 (en) 2008-06-05
GB0421465D0 (en) 2004-10-27
WO2006035311A3 (en) 2006-05-18
JP2008514196A (ja) 2008-05-08
WO2006035311A2 (en) 2006-04-06
EP1794186A2 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
CN100381464C (zh) 脑膜炎球菌蛋白nmb1870的多种变异体
KR101748453B1 (ko) 폐렴구균(Ｓｔｒｅｐｔｏｃｏｃｃｕｓ Ｐｎｅｕｍｏｎｉａｅ)에 대항하는 백신과 조성물
DK2248822T3 (en) MENINGOCOKKER ADHESIONS
US7270827B2 (en) Multivalent streptococcal vaccine compositions and methods for use
JP2002516571A (ja) Ｅｎｔｅｒｏｃｏｃｃｕｓ ｆａｅｃａｌｉｓポリヌクレオチドおよびポリペプチド
EP1828231A2 (en) Group b streptococcus
KR20140017554A (ko) 폐렴 구균에 대한 백신 및 조성물
KR20160127104A (ko) 변형된 수막구균 fhbp 폴리펩티드
CN103974718A (zh) 基于艰难梭菌毒素的疫苗
JP2011062203A (ja) ビルレンス関連付着因子
RU2252224C2 (ru) Пептид со свойствами антигена neisseria meningitidis, кодирующий его полинуклеотид, вакцина для лечения или предотвращения заболеваний или состояний, вызванных neisseria meningitidis, (варианты), антитело, связывающееся с указанным пептидом
US20080131465A1 (en) Group a Streptococcus Crge Protein
US20130243779A1 (en) Peptides protective against e. faecalis, methods and uses relating thereto
US20200030430A1 (en) Immunogenic compositions
EP2841096B1 (en) Antigens and antigen combinations
US20080166370A1 (en) Immunogenic Compositions Comprising Multiple Gonococcal Antigens
JP2016539950A (ja) 細菌表面受容体タンパク質由来の免疫原性組成物およびワクチン
Du Investigation of the role of Streptococcus pneumoniae surface proteins PspA and PspC
Hajishengallis Peptide mapping of a functionally versatile fimbrial adhesin from Porphyromonas gingivalis
WO2005023851A1 (en) Plasminogen/plasmin binding polypeptides and nucleic acids therefore
US20060198852A1 (en) Collagen-binding MSCRAMMs of Bacillus anthracis and uses therefor
Achila Molecular basis of pneumococcal adherence and complement evasion: Structural and biochemical studies of pneumococcal virulence factor, CbpA
HK1088342B (en) Multiple variants of meningococcal protein nmb1870
JP2009520491A (ja) 髄膜炎菌に対するワクチン

Legal Events

Date Code Title Description
FZDE Discontinued